Ticker Scorecard - PCVX Basics Company: Vaxcyte, Inc. IPO Date: July 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $9.94B Activated in VL: True Average Daily Range Avg Daily Range: $1.01 | 2.50% Avg Daily Range (30 D): $2.12 | 2.48% Avg Daily Range (90 D): $1.94 | 2.09% Institutional Daily Volume Avg Daily Volume: .47M Avg Daily Volume (30 D): .89M Avg Daily Volume (90 D): .87M Trade Size Avg Trade Size (Sh.): 58 Avg Trade Size (Sh.) (30 D): 51 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 2,732 Avg Inst. Trade: $3.81M Avg Inst. Trade (30 D): $6.11M Avg Inst. Trade (90 D): $6.24M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $6.98M Avg Closing Trade (30 D): $13.32M Avg Closing Trade (90 D): $16.48M Avg Closing Volume: 120.19K     News Jan 30, 2025 @ 4:51 PM Kuehn Law Encourages Investors of Vaxcyte, Inc. to... Source: N/A Jan 1, 2025 @ 9:27 AM Trump and Interest Rates: The 2 Key Reasons This V... Source: Anthony Di Pizio Sep 5, 2024 @ 3:58 AM Vaxcyte Announces Pricing of $1.3 Billion Public O... Source: N/A Sep 3, 2024 @ 8:01 PM Vaxcyte Announces Commencement of Proposed Public ... Source: N/A Sep 3, 2024 @ 1:40 PM Bacterial Infections Vaccine Developer Vaxcyte's P... Source: Vandana Singh Financials   TTM Q3 2024 Q2 2024 Basic EPS $-4.6 $-.83 $-1.1 Diluted EPS $-4.6 $-.83 $-1.1 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -507.65M $ -103.12M $ -128.7M Operating Income / Loss $ -604.05M $ -139.92M $ -152.98M Cost of Revenue $ $ $ Net Cash Flow $ 505.27M $ 531.73M $ -92.84M PE Ratio